News

The label will contain a boxed warning, which increases the prominence of an already existing warning for all medicines in the TZD class on the risk of congestive

CombinatoRx says it selected CRx-401 for clinical evaluation based on preclinical data demonstrating decreased fasting glucose and insulin resistance without weight gain. According to the company, CRx-401 offers

GSK-923295 is a small-molecule inhibitor of centromere-associated protein E (CENP-E). As reported at the 2007 annual meeting of the American association for cancer research (AACR), GSK-923295 demonstrated a

The manufacturing facility is located near Baltimore, Maryland. Once fully built out to Cel-Sci’s specifications, the facility will produce Multikine for both its Phase III clinical trials for

GSK says severe, dehydrating gastroenteritis occurs primarily among children aged three to 35 months. Of children hospitalized with rotavirus, approximately 17% are younger than six months old. If

NXN-188 is a first-in-class, dual-action, small molecule that is being developed for the treatment of acute migraine and which incorporates both 5-HT agonism (the mechanism of action of

According to the company, results showed that administration of oral Adentri for 10 days, in addition to standard heart failure therapy, was well tolerated and resulted in clinically

The agreement gives Argentis the rights to the treatment, as well as the processes involved in manufacturing the pharmaceutical product. Systemic sclerosis (SSc or systemic scleroderma) is an

On February 8, 2007 in laboratories at the University of Navarra, Pamplona, Spain, professor Jose Obeso transplanted the subject, a healthy monkey, with BrainStorm’s human bone marrow derived